Podcast appearances and mentions of Richard Bernstein

On episode 193 of The Compound and Friends, ⁠⁠Michael Batnick⁠⁠ and ⁠⁠Downtown Josh Brown⁠⁠ are joined by Richard Bernstein to discuss: the Big Beautiful Bill, the bond market, the Fed, the next recession, international stocks, the best uncertainty hedge, and much more! This episode is sponsored by Kraneshares. Read their recent article on the future of AI at: https://KraneShares.com/ai Sign up for The Compound Newsletter and never miss out: ⁠⁠thecompoundnews.com/subscribe⁠⁠ Instagram: ⁠⁠instagram.com/thecompoundnews⁠⁠ Twitter: ⁠⁠twitter.com/thecompoundnews⁠⁠ LinkedIn: ⁠⁠linkedin.com/company/the-compound-media/⁠⁠ TikTok: ⁠⁠tiktok.com/@thecompoundnews⁠⁠ Investing involves the risk of loss. This podcast is for informational purposes only and should not be or regarded as personalized investment advice or relied upon for investment decisions. Michael Batnick and Josh Brown are employees of Ritholtz Wealth Management and may maintain positions in the securities discussed in this video. All opinions expressed by them are solely their own opinion and do not reflect the opinion of Ritholtz Wealth Management. The Compound Media, Incorporated, an affiliate of ⁠⁠Ritholtz Wealth Management⁠⁠, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. For additional advertisement disclaimers see here ⁠⁠https://ritholtzwealth.com/advertising-disclaimers⁠⁠. Investments in securities involve the risk of loss. Any mention of a particular security and related performance data is not a recommendation to buy or sell that security. The information provided on this website (including any information that may be accessed through this website) is not directed at any investor or category of investors and is provided solely as general information. Obviously nothing on this channel should be considered as personalized financial advice or a solicitation to buy or sell any securities. See our disclosures here: ⁠⁠https://ritholtzwealth.com/podcast-youtube-disclosures/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Markets weigh mega-cap momentum against rising caution with Ryan Detrick of Carson Group and Richard Bernstein of RBA debating. Key takeaways from Nvidia and Microsoft's moves, while Jason Furman, former CEA Chair, breaks down budget bill risks and the deficit. Plus, Dan Niles weighs in on tech and the economy and why he sees fresh lows later this year and our Leslie Picker on the quiet race to succeed Jamie Dimon.

About Only in AmericaA probing biography of world-renowned Jewish singer and actor Al Jolson and the history of his performance in and the making of The Jazz Singer.About the AuthorRICHARD BERNSTEIN has been a reporter, culture critic, and commentator for more than thirty years. He was a foreign correspondent in Asia and Europe for Time and The New York Times, and was the first bureau chief in China for Time. He is the author of several books, among them China 1945; A Girl Named Faithful Plum; Ultimate Journey, a New York Times Best Book of the Year; and Out of the Blue, named one of the seven best books of the year by The Boston Globe. He lives in New York City.

Send us a textSusan Colonna is a retired Registered Nurse, having received her Bachelor of Science degree in Nursing from Texas Woman's University in 1992. She has been passionate about natural health remedies and regular exercise for her entire life.In her 40's, Susan was a sponsored athlete and a national-level competitive bikini level bodybuilder and achieved a high level of success by taking 2nd place at the North American NPC National finals in 2014. She is the mother of 4 adult kids and is a grandmother of 2.In January of 2023 Susan was diagnosed with type one diabetes, and she witnessed firsthand how the medical system completely failed her. Today, Susan is enthusiastic about sharing her story about how medical doctors refused to give her insulin, which is insane, but instead would give Ozempic to her, which led her to experience shock, pancreatitis, and eventually a near-death experience.Today she is extremely outspoken about the benefits of the carnivore diet, and she encourages others to be their own health advocates.Find Susan at-TW- @truthhhseekerFB- @Susan Parker Colonnahttps://yandex.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Eli Lilly will start a lcinical trial for tirzepatide for people with type 1 diabetes, more details on Dexcom's 15 day G7 sensor, Ozepmic pill form tested, type 5 diabetes identified and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week.. Eli Lilly takes the first steps toward getting tirzepatide approved for people with type 1 diabetes. Tirzepatide is sold under the brand names Mounjaro for type 2 and Zepbound for obesity. The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or are overweight. Participation in the study will last about 49 weeks. Official Title A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight This is a big deal because, even though many people with type 1 are able to get a prescription for tirzepatide, it's not approved for T1D and so insurers won't usually cover it.   https://clinicaltrials.gov/study/NCT06914895 XX The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there's little information on the drugs' safety and effectiveness for the condition. The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. But the clinical trials of these medications specifically excluded people with type 1 diabetes, who are dependent on the hormone insulin to survive because they can't make enough of their own. Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them in people with type 1.   For the study, which was published last month in the journal Diabetes, Obesity, and Metabolism, researchers at Johns Hopkins University reviewed the medical records of more than 200,000 people with type 1 diabetes from 2008 to 2023. They grouped the data in three-year periods, starting with October 2008 to September 2011 and ending with October 2020 to September 2023. GLP-1 medication use spiked, as well. Among adults with the highest category of obesity, about 4% used GLP-1 medications in 2008, and 33% did by 2023 – an 800% increase. But these are anecdotal reports and may not reflect instances in which people have side effects or complications like low blood sugar, which can be life-threatening. But Shin says what's really needed is information from randomized, double-blinded studies, in which participants are followed forward in time and given either a drug or a placebo. https://www.cnn.com/2025/04/09/health/glp-1-type-1-diabetes-study/index.html   XX Later this month the FDA will conduct a final meeting regarding a new, investigational compound (sotagliflozin) soda-GLIFF-a-zin that has been shown to Improve QoL and Reduce Long-term Complications for people with type 1 diabetes (T1D). The patient advocacy group Taking Control of Your Diabetes (TCOYD.org) is working to inform the T1D community about sotagliflozin - and to encourage people to sign a Change.org petition directed towards FDA.  Last fall, the FDA declined to approve sotagliflozin due to concerns about a potential increased risk of diabetic ketoacidosis (DKA), despite this being a condition that people with T1D on insulin face and manage daily. While TCOYD respects FDA's caution, the group stands by T1D patients and their physicians who, as a team, balance risks and benefits every day. https://tcoyd.org/petition/ XX Dexcom receives FDA approval for it's G7 with 15 day wear. We have an interview with Chief Operating Officer Jake Leach coming up on Tuesday – we talk about the planned roll out of this sensor, what else has changed, and the fine print in the press release – it says    “A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days.   https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Receives-FDA-Clearance-the-Longest-Lasting-Wearable-and-Most-Accurate-CGM-System/default.aspx?utm_source=www.diabetech.info&utm_medium=referral&utm_campaign=dexcom-g7-15-day-sensor-gets-fda-cleared-but-will-it-actually-last-that-long   XX Glucotrack is joining something called  FORGETDIABETES bionic pancreas initiative, - this is an European Union project that aims to develop a long-term automated insulin delivery system for type 1 diabetes patients. Glucotrack's Continuous Blood Glucose Monitor (CBGM) will be integrated into the system to provide real-time glucose readings. The initiative's goal is to create a bionic invisible pancreas that eliminates the need for therapeutic actions and reduces psychological burden.   The architecture of BIP encompasses a ground-breaking, lifelong lasting implanted ip glucose nanosensor; a radically novel ip hormone delivery pump, with unique non-invasive hormone refill with a magnetic docking pill and non-invasive wireless battery recharge; an intelligent closed-loop hormone dosing algorithm, optimized for ip sensing and delivery, individualized, adaptive and equipped with advanced self-diagnostic algorithms.     Pump refilling through a weekly oral recyclable drug pill will free T1D subjects from the burden of pain and awkward daily measurement and treatment actions. Wireless power transfer and data transmission to cloud-based data management system round-up to a revolutionary treatment device for this incurable chronic disease. key feature of BIP is to be fully-implantable and life-long lasting thanks to novel biocompatible and immune-optimized coatings guaranteeing long-term safety and stability https://www.stocktitan.net/news/GCTK/glucotrack-to-participate-in-forgetdiabetes-a-prominent-european-cjjldjb0dq7h.html XX A newly recognised form of diabetes, called Type 5, was announced this week at the World Congress of Diabetes 2025. A global task force will investigate this less-understood condition, which differs from Type 1 and Type 2 diabetes. Type 5 diabetes affects people who are underweight, lack a family history of diabetes and do not show the typical symptoms of Type 1 or Type 2 diabetes. The condition was first observed in the 1960s and referred to as J-type diabetes, after being detected in Jamaica. It was classified by the World Health Organisation in 1985, but removed in 1998 due to lack of physiological evidence. At the time, experts believed it to be a misdiagnosed case of Type 1 or 2 diabetes. New research has since confirmed that Type 5 is different. https://economictimes.indiatimes.com/news/new-updates/a-new-type-of-diabetes-has-been-found-by-scientists-and-it-doesnt-show-the-typical-symptoms-of-type-1-or-type-2/articleshow/120276658.cms?from=mdr   XX Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. A new clinical trial, co-led by endocrinologist and diabetes specialist John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine, has demonstrated that the oral form of semaglutide significantly lowers the risk of cardiovascular events in individuals with type 2 diabetes, atherosclerotic cardiovascular disease, and/or chronic kidney disease. Results from the rather large, international trial were published in the New England Journal of Medicine and presented at the American College of Cardiology's Annual Scientific Session & Expo in Chicago, Illinois.     The effect of oral semaglutide on cardiovascular outcomes was consistent with other clinical trials involving injectable semaglutide, but more trials are needed to determine if one method may be more effective than the other at reducing major cardiovascular events. https://scitechdaily.com/new-pill-form-of-semaglutide-shows-major-benefits-for-people-with-diabetes/ XX April 14 (UPI) -- The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States. Novo Nordisk, the Danish-headquartered manufacturer, informed the FDA on April 3 that counterfeit 1-milligram injections of semaglutide were being distributed outside its authorized supply chain. The FDA and Novo Nordisk are testing the fake products to identify whether they're safe. Patients are asked to obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for any signs of counterfeiting. People in possession of the fake product are urged to call Novo Nordisk customer care at 800-727-6500 Monday through Friday from 8:30 a.m. to 6 p.m. EDT and report it to the FDA's criminal activity division's website. Side effects can be reported to FDA's MedWatch Safety Information and Adverse Event Reporting Program (800-FDA-1088 or www.fda.gov/medwatch) as well as to Novo Nordisk, at 800-727-6500. https://www.upi.com/Health_News/2025/04/14/FDA-fake-Ozempic-drugs-Novo-Nordisk/6841744666854/ XX Can a digital lifestyle modification program reduce diabetes risk? A new study shows that the lifestyle intervention significantly reduced 10-year diabetes risk among prediabetics by nearly 46% and increased the diabetes remission rate, highlighting the importance of lifestyle changes. However, the study was not a randomized trial, and participation in the lifestyle intervention was voluntary, which may introduce selection bias. The study evaluated 133,764 adults, categorizing them as diabetic (7.5%), prediabetic (36.2%), and healthy (56.3%), based on fasting glucose and HbA1c levels. https://www.news-medical.net/news/20250414/Digital-lifestyle-program-cuts-diabetes-risk-by-4625-in-prediabetics-study-of-130k2b-adults-reveals.aspx XX Chrissy Teigan is speaking out about her son's type 1 diagnosis – teaming up with Sanofi to encourage people to screen early for Type 1 diabetes.   Teigen got a crash course in the risks of undiagnosed Type 1 diabetes when her 6-year-old son, Miles, was hospitalized with complications of the autoimmune disease last year. The family knew nothing about Type 1 diabetes when Miles was diagnosed during an unexpected medical emergency, Teigen said in a Tuesday announcement. “We were confused and scared when Miles was first diagnosed,” she said in a statement. “There is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!”   Teigen shared her family's story in a two-minute video on ScreenForType1.com, a Sanofi website that discusses how to get screened for the condition. Miles' diagnosis made Teigen feel like she “went from a mom to a doctor overnight,” she said. That experience is why Teigen said she is “begging you: Do this one thing, and screen yourself and your family for Type 1 diabetes.” https://www.fiercepharma.com/marketing/sanofi-signs-chrissy-teigen-diabetes-screening-campaign XX Dr. Richard Bernstein – best known for his advocacy around low carb diets for people with diabetes – died this week at the age of 90. Born in 1934 in Brooklyn, New York, he was diagnosed with type 1 at age 12. In the 1970s he adapted a blood glucose monitor for home use and helped pioneer home glucose monitoring. He published multiple books on Diabetes including the #1 selling Diabetes book on Amazon.Com “Dr. Bernstein's Diabetes Solution: A Complete Guide to Achieving Normal Blood Sugars” and “Diabetes Type II: Living a Long, Healthy Life Through Blood Sugar Normalization”.  He practiced and saw patients right up until his death.

Errol Morris movie about investing.  Dan liked it.  Also A Real Pain.  Saving the Metro Theater (NYC).  Kelvin Sampson.  Remembering William Finn.  Richard Bernstein.  Linda Williams, professor, and how her porno-film theories intersected with Dan's legal career.  Clive Revill. Credits: Talent:  Tamsen Granger and Dan Abuhoff Engineer:  Ellie Suttmeier Art:  Zeke Abuhoff

Join hosts Matt Zeigler and Justin Carbonneau as they sit down with Richard Bernstein, CEO and Chief Investment Officer of Richard Bernstein Advisors. In this insightful conversation, Rich shares his expert perspective on today's market challenges, including the unprecedented narrowness of recent markets, the impact of tariffs on the US economy, and why the current environment calls for a shift toward value investing and greater diversification. Drawing on decades of experience, Bernstein offers practical wisdom for navigating today's uncertain investment landscape.Topics Covered:The difference between the 2008 financial crisis and today's economic challengesWhy 2023-2024 saw the most narrow stock market since the Great DepressionThe potential impact of tariffs as "the biggest tax on consumers in our professional careers"Why investors should err on the side of value over growth in the current marketHow US debt levels impact interest rates and economic competitivenessThe role of the Federal Reserve as a lagging rather than leading indicatorWhy gold serves as an effective hedge against uncertaintyBernstein's skeptical view on cryptocurrency and Bitcoin valuationThe limitations of index funds in today's market environmentTimeless advice for wealth building: stick to fundamentals and avoid "get rich quick" thinking

Richard Bernstein Advisors CEO Richard Bernstein says "the Fed is caught between a rock and a hard place. GDP forecast has been downward, but inflation expectations seem poised to accelerate." Bernstein spoke with Bloomberg's Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern.See omnystudio.com/listener for privacy information.

What happens when you combine an uncertain macro environment with an incredibly certain investor base? You get a whole lot of volatility, according to Richard Bernstein. Bernstein is the CEO and Chief Investment Officer at Richard Bernstein Advisors. He joins Ricky Mulvey for a conversation about: - Trade wars - Degloblalization - The crypto industry - And how investors ought to make sense of the news. Host: Ricky Mulvey Guest: Richard Bernstein Producer: Mary Long Engineer: Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

Dan Suzuki serves as the Deputy Chief Investment Officer of Richard Bernstein Advisors (RBA). Dan shares his take on a wide range of topics that have recently influenced investor sentiment and moved markets, including US trade policy, growth concerns, and the progression of artificial intelligence. We also outline a market outlook and discuss asset allocation considerations. Host: Daniel Cassidy Recorded on 03.13.25.

Companies, investors, and countries are all having a hard time knowing what the future holds. And that makes forecasting hard. (00:21) Jason Moser and Matt Argersinger discuss: - The market's correction reaction to tariffs, and what higher prices might mean for consumers that are already spending less. - The market's questions around Tesla's tough start to 2025, slipping european sales, and Elon Musk. - Earnings from Adobe, Vail, and Docusign. (19:22) Macro-focused investor Richard Bernstein walks Ricky Mulvey through the big picture he's seeing, and how tariffs, trade uncertainty, and how it all flows into what we've seen in the stock market over the past few weeks. (32:51) Jason and Matt break down where they turn to celebrate Pi Day and two stocks on their radar: Ansys and Starbucks. Stocks discussed: TSLA, ADBE, MTN, DOCU, ANSS, SBUX Host: Dylan Lewis Guests: Jason Moser, Matt Argersinger, Richard Bernstein, Ricky Mulvey Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Harry and Daniel are joined by special guest Richard Bernstein, author of Only in America, to explore the groundbreaking yet controversial 1927 film The Jazz Singer. As the first feature-length "talkie," The Jazz Singer revolutionized Hollywood, but its themes of assimilation, the American Dream, and generational conflict remain just as compelling today.The conversation delves into Al Jolson's electrifying performance, the film's cultural impact, and the complicated legacy of both the movie and its star—including the troubling use of blackface, which continues to spark debate.Plus, they trace The Jazz Singer's origins—from short story to stage play to cinematic milestone—and consider how it shaped portrayals of Jewish identity on screen. Tune in for a fascinating discussion about one of the most significant (and controversial) films in Jewish and Hollywood history.Buy Richard's book, Only in America - https://bookshop.org/p/books/only-in-america-al-jolson-and-the-jazz-singer-richard-bernstein/20143816The Jazz Singer on IMDb - https://www.imdb.com/title/tt0018037/The Jazz Singer on YouTube - https://youtu.be/PMvn8Ws-l0cConnect with Jews on Film online:Jews on Film Merch - https://jews-on-film.printify.me/productsInstagram - https://www.instagram.com/jewsonfilm/Twitter - https://twitter.com/jewsonfilmpodYouTube - https://www.youtube.com/@jewsonfilmTikTok - https://www.tiktok.com/@jewsonfilmpod

Richard Bernstein is a reporter, foreign correspondent, and cultural critic whose latest book is Only in America: Al Jolson and The Jazz Singer. Co-hosts: Jonathan Friedmann & Joey Angel-Field Producer-engineer: Mike Tomren Richard's websitehttps://www.richardbernstein.net/ Only in Americahttps://www.penguinrandomhouse.com/books/703276/only-in-america-by-richard-bernstein/ The Jazz Singer (1927)https://www.youtube.com/watch?v=PMvn8Ws-l0c Amusing Jews Merch Storehttps://www.amusingjews.com/merch#!/ Subscribe to the Amusing Jews podcasthttps://www.spreaker.com/show/amusing-jews Adat Chaverim – Congregation for Humanistic Judaism, Los Angeleshttps://www.humanisticjudaismla.org/ Jewish Museum of the American Westhttps://www.jmaw.org/ Atheists United Studioshttps://www.atheistsunited.org/au-studios

Today's guest is Chuck Clough, Chief Investment Officer of Clough Capital. Chuck is well known from his time as the Chief Global Investment Strategist at Merrill Lynch until 2000 and has spent over six decades in finance. In today's episode, Chuck shares insights from his illustrious career, reflecting on the challenges of the 1970s and the market crash of 1987. Chuck explains what it was like to be bearish during the dot-com bubble and watch Cisco go up 6x after he turned bearish, only to then decline by 95%. He compares the current stock market to the dot-com bubble, talks about the impact of AI on various sectors, and finishes with lessons from working alongside legends like Bob Farrell & Richard Bernstein. (0:00) Starts (0:34) Sponsor: Farmland LP (1:40) Introduction of Chuck Clough (5:14) 1970s inflation (11:57) Comparing the 1999 dot-com bubble to today (14:08) Predictions for AI companies (24:13) Clough Capital and views on China (28:09) Interest rates, inflation, and demographics (33:09) Savings, investment, and the productivity impact of AI (38:30) Investment opportunities in various industries (47:11) Contrarian views (50:50) Financial market surprises (56:37) Chuck's most memorable investment ----- For detailed show notes, click here ----- Farmland LP is one of the largest investment funds in the US focused on converting chemical-based conventional farmland to organic, sustainably-managed farmland using a value-add commercial real estate strategy in the agriculture sector. Register here for their webinar on March 12.  ----- Follow Meb on X, LinkedIn and YouTube To learn more about our funds and follow us, subscribe to our mailing list or visit us at cambriainvestments.com Follow The Idea Farm: X | LinkedIn | Instagram | TikTok ----- Interested in sponsoring the show? Email us at Feedback@TheMebFaberShow.com ----- Past guests include Ed Thorp, Richard Thaler, Jeremy Grantham, Joel Greenblatt, Campbell Harvey, Ivy Zelman, Kathryn Kaminski, Jason Calacanis, Whitney Baker, Aswath Damodaran, Howard Marks, Tom Barton, and many more.  ----- Meb's invested in some awesome startups that have passed along discounts to our listeners. Check them out here!  ----- Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). The Clough ETFs are distributed by Paralel Distributors, LLC. Paralel Distributors, LLC and Clough Capital Partners L.P. are not affiliated. Please read Clough Capital's disclosures and a prospectus at cloughetfs.com/disclosures before investing. Learn more about your ad choices. Visit megaphone.fm/adchoices

Why Must I Die (1960)AIP Production #504 Jeff and Cheryl strap in for an emotional tale about the application (and misapplication) of the death penalty in Why Must I Die. Directed by Roy Del Ruth Screenplay by Richard Bernstein and George W. Waters Story by George W. Waters Produced by Richard Bernstein Cast:Terry Moore as Lois King Debra Paget as Dottie Manson Bert Freed as Adler Juli Reding as Mitzi Lionel Ames as Eddie Rainey Richard Le Pore as Sinclair Sid Melton as Morrie Waltzer Selette Cole as Peggy Taylor Dorothy Lovett as Mrs Benson Phil Harvey as Kenny Randall Fred Sherman as Red King Robert Shayne as Charlie Munro Damian O'Flynn as District Attorney Walter Dennison Holly Harris as Miss Bradley, the Superintendent Mark Sheeler as Jim Jhean Burton as Trixie Abbagail Shelton as Dawn Jackie Joseph as Marge Brennan the Cigarette Girl (uncredited)  A Viscount-Terry Moore Production An American International Picture 

Send us a textBethany McKenzie was thrust into the world of type one diabetes when her son was diagnosed with the disease in 2015. She discovered this when Bethany came back from a trip, when she noticed her son, River,  had lost weight, dropping from 46 to 40 lbs. Immediately, she rushed him to the hospital, and he was diagnosed. For several years, Bethany followed their rules, only to find that her son felt truly terrible and unhealthy, experiencing headaches, and high blood sugar.Eventually, she realized that she would have to change the way that her family ate, despite the advice from her doctors and dieticians. Bethany found low-carbohydrate diets that have, with careful control, worked wonders for her son and for her family.She is the executive producer of the incredible documentary “The Diabetes Solution”, modeled after the work of Dr. Richard Bernstein in the field of diabetes and insulin.She is also the founder of Let Me Be 83, a movement by the Rivere Foundation. They advocate for an alternative diabetes management regimen, anchored in nutrition and the proper use of insulins, that allows people with diabetes to achieve healthy blood glucose levels. Find Bethany at-FB- @Let Me Be 83https://letmebe83.org/about/Find Boundless Body at- myboundlessbody.com Book a session with us here!

Join us for an inspiring and thought-provoking conversation with Supreme Court Justice Richard Bernstein, a longtime friend of MJE and a true testament to perseverance and vision. Born blind, Justice Bernstein has defied expectations, becoming a trailblazer in law, an advocate for peace, and a marathon runner who challenges limits in every aspect of life.In this episode, we delve into his remarkable journey, including his role in advancing the Abraham Accords and promoting peace in the Middle East. Justice Bernstein shares profound insights on the beauty of his disability, his unwavering faith in God, and how it has shaped his perspective on justice, resilience, and advocacy.0:00 Introduction2:43 Serving as a Judge in MI4:00 Resilience10:15 Resilience15:15 Identifying Purpose Through Judaism16:02 Wrongful Convictions20:34 Flint Water Case23:26 Talmudic Perspective on Wrongful Convictions24:18 Has DNA Been Helpful in Court?28:47 Overcoming Adversity with One's Mission35:26 Disability Advocacy in the Middle East50:04 Importance if the Abraham Accords52:18 Rabbi Nebenzahl59:07 Everybody is Touched by Disability1:00:32 Perception of Disabilities in the Arab World1:04:25 Collaboration with a Sheikh1:07:21 Peace with Saudi Arabia1:08:41 Opening MI Back Up During Covid1:11:15 Long Term Consequences of Covid Lockdown1:13:56 Bringing People Together1:16:23 Conclusion

Richard Bernstein provides his perspective on key investment themes to watch in the year ahead, including overlooked opportunities, potential pitfalls, and the value of seeking “maximum diversification”.----------------------------------------------------------------------------------------------Website: First Trust PortfoliosConnect with us on LinkedIn: First Trust LinkedInFollow us on X: First Trust on XSubscribe to the First Trust YouTube ChannelSubscribe to the ROI Podcast YouTube Channel

Send us a textR.D. Dikeman, PhD, is a theoretical physicist and loving husband of Roxanne Dikeman, PhD, a clinical psychologist. Their world was turned upside down when their young son David was diagnosed with type 1 diabetes.After following conventional dietary advice for this condition led to uncontrollable blood sugar, dangerous “hypos,” and many sleepless nights, R.D. discovered the work of Dr. Richard Bernstein, MD, a medical doctor who has used a low-carb diet to control his own type 1 diabetes for more than fifty years and pioneered some of the most groundbreaking research on low-carb diets for diabetes in the modern era.Through working closely with Dr. Bernstein and as a founder of the TypeOneGrit online community, R.D. has helped provide thousands of other individuals and families living with type 1 diabetes with information to reduce the threat of complications and attain the truly normal blood sugars that all type 1 diabetics deserve.TypeOneGrit is an amazing FB group of type 1 diabetics who are following Dr. Bernstein and his protocol which consists of a VERY low carb diet- no grains, no sugar, no starch, and no fruit, to normalize blood sugars.Find RD Dikeman at-FB- @typeonegritFB- @DiabetesUniversityTW- @DikemanDaveResources-Amazon- Dr. Bernstein's Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugarshttps://letmebe83.org/Find Boundless Body at- myboundlessbody.com Book a session with us here!

As 2025 quickly approaches, Rich rejoins Jason for a year-ahead discussion, spanning the macroeconomic environment, to markets, to the landscape across Washington DC. We also spend time reviewing investment themes in-focus, along with allocation preferences across asset classes. Featured are Jason Draho, Head of Asset Allocation Americas with the UBS Chief Investment Office, and Richard Bernstein, Founder, Chief Executive Officer and Chief Investment Officer of Richard Bernstein Advisors (RBA). Host: Daniel Cassidy

Mike Contopoulos rejoins Leslie Falconio for a discussion around year-end asset class performance expectations, potential outcome implications of the US election for fixed income investors, positioning, and more. Featuring Mike Contopoulos, Director of Fixed Income for Richard Bernstein Advisors, as well as Leslie Falconio, Head of Taxable Fixed Income Strategy Americas with the UBS Chief Investment Office. Host: Daniel Cassidy

Dan Suzuki serves as the Deputy Chief Investment Officer for Richard Bernstein Advisors (RBA). Dan drops by the 1285 podcast studio in New York to share his US economic outlook, thoughts on Q3 corporate earnings, equity valuations, monetary policy, and more. Plus, we spend time highlighting where opportunities can be located. Host: Daniel Cassidy

Welcome to another episode of Think Smart with TMFG, your go-to podcast for newsworthy and relevant financial insights for Canadians. Join your hosts, Senior Financial Advisor Rob McClelland and Mike Connon from Assante Capital Management, as they delve into the pressing question: "Does Value Matter Anymore?" This week, Rob and Mike explore an insightful article by Richard Bernstein discussing the current state of value investing in today's market. Despite value investing's underperformance compared to growth investing over the past 20 years, they emphasize its long-term benefits and why it remains a cornerstone of their investment strategy. Using relatable analogies like grocery shopping at Walmart vs. Longo's, they break down the concept of value investing and its historical outperformance. They also touch on the human tendency to follow trends and how this impacts market behavior, particularly with high-flying tech stocks like Google, Apple, and Nvidia. Join Rob and Mike as they share personal stories and practical examples, from buying groceries and houses to choosing the right car, all to illustrate the enduring principles of value investing. Learn why patience and a focus on value can lead to sustainable long-term gains, even in a market enamored with growth. Tune in to understand why value investing is not just a strategy but a mindset that could be crucial for your financial future.

In this episode, Ryan looks back at the first half of 2024, highlighting some of the key insights provided by guests of the podcast—including Bob Stein, Brian Wesbury, Jim Murchie, and Richard Bernstein.  He also reveals plans for the second half of the year.Reach us at https://www.ftportfolios.com/Connect with us on LinkedIn https://www.linkedin.com/company/first-trust/Follow us on 'X' @ftportfolios

Part 2 of 2 Noted strategist and asset allocator Rich Bernstein shares the most important investment lessons learned from the markets in the 20 years since WEALTHTRACK launch, in part 2 of his interview. WEALTHTRACK episode 2102 broadcast on July 12, 2024 More info: https://wealthtrack.com/key-investment-lessons-of-the-last-20-years-from-noted-strategist-richard-bernstein/ Bookshelf: Bookshelf: Navigate the Noise: Investing in the New Age of Media and Hype https://amzn.to/3VRLCvA Stocks for the Long Run, 6th Edition https://amzn.to/3Wh25uJ --- Support this podcast: https://podcasters.spotify.com/pod/show/wealthtrack/support

Influential strategist Richard Bernstein reflects on the most successful investment themes of the last twenty years and explains why deglobalization and the concomitant reindustrialization of America are his number one themes now. More info: https://wealthtrack.com/strategist-richard-bernstein-on-successful-investment-themes-of-the-past-and-his-favorite-one-now/ Bookshelf: Navigate the Noise: Investing in the New Age of Media and Hype https://amzn.to/3VRLCvA --- Support this podcast: https://podcasters.spotify.com/pod/show/wealthtrack/support

Please visit answersincme.com/XFG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in vascular neurology discusses the data and the implications for inhibiting coagulation factor XIa (FXIa) as a therapeutic option in stroke prevention. Upon completion of this activity, participants should be better able to: Identify the rationale for inhibiting FXIa as a therapeutic option in stroke prevention; Describe the latest clinical data for oral FXIa inhibitors in stroke prevention; and Review the implications of the latest FXIa inhibitor data for the future of stroke prevention.

Richard Bernstein, CEO/CIO of Richard Bernstein Advisors, discusses deglobalization, the reindustrialization of America, and how most investors are ignoring one of the most powerful secular growth opportunities today.Reach us at https://www.ftportfolios.com/Connect with us on LinkedIn https://www.linkedin.com/company/first-trust/Follow us on 'X' @ftportfolios

RichardBernstein is the chief executive officer/chief investment officer of Richard Bernstein Advisors LLC. The firm utilizes a unique top-down approach to investing, focusing on macro trends rather than individual stock selection. RBA is one of the fastest growing money management firms, is among Morningstar's Top 10 ETF Model Managers in assets and partners with some of the world's leading financial institutions. Mr. Bernstein has over 40 years' experience on Wall Street, and was formerly the Chief Investment Strategist at Merrill Lynch & Co. Prior to joining Merrill Lynch in 1988, he held positions at E.F. Hutton and Chase Econometrics/IDC. A much-noted expert on equity, style and asset allocation, Mr. Bernstein was voted to Institutional Investor magazine's annual “All-America Research Team” eighteen times and is one of only fifty-seven analysts inducted into the Institutional Investor “Hall of Fame”. He was also twice named to both Fortune magazine's “All-Star Analysts” and to Smart Money magazine's “Power 30” and was a member of Registered Rep's “Ten to watch” for 2012. His book “Style Investing: Unique Insight into Equity Management” is widely viewed as the seminal book on style-oriented investment strategies. He donates the profits from that and his other book, “Navigate the Noise: Investing in the New Age of Media and Hype,” to charity. Mr. Bernstein is chair of the Alfred P. Sloan Foundation endowment's Investment Committee (~$2.0 billion) and sits on the Hamilton College endowment's Investment Committee (~$1 billion); he is a trustee of both institutions. Rich holds an MBA in finance, with Beta Gamma Sigma distinction, from New York University, and a BA in economics from Hamilton College. He has lectured on finance and economics at numerous colleges, universities, and professional forums.

Dan rejoins the podcast to provide his near-to-medium term outlook for the US economy, monetary policy, and equity markets. We also discuss where Dan is finding opportunity within equities, as well as the risks to be mindful of as we approach 2H24. Featured is Dan Suzuki, Deputy Chief Investment Officer at Richard Bernstein Advisors. Host: Daniel Cassidy

We often allow situations we go through in life to determine the outcome, yet we have the ability to make them work in our favor. Join us in today's empowering conversation with Michigan State Supreme Justice Richard Bernstein, a remarkable individual who defies limitations. Blind from birth to serving on the highest court in the state of Michigan, meet Supreme Court Justice Richard Bernstein. Justice Bernstein's journey is one of resilience and triumph. With over 20 marathons, a triathlon, and an iron-man on his endurance resume, and thousands of cases under his purview. Despite going through a traumatic accident and situational depression, he emerged stronger than ever. He advocates for disability rights and champions for impactful legal decisions. Within every obstacle lies an opportunity for growth. In this episode you'll learn: Leverage setbacks and pain to channel the best version of you Strategies to handle situational depression and trauma How accommodations can be used to empower individuals with disabilities to foster inclusion and create opportunitiesFind meaning in everyday experiences 00:00 - Introduction to Justice Richard Bernstein 01:16 - Justice Bernstein's approach to life's challenges 02:53 - Becoming an attorney to empower others 04:04 - Overcoming challenges of being blind in law 05:49 - Memorization techniques for legal work 06:51 - Accommodations as the great equalizer 08:50 - Reframing challenges as stepping stones 09:44 - Finding strength through athletics 12:07 - Impact of Justice Bernstein's story on others 16:25 - Dealing with imperfections and mistakes 18:18 - Handling gravity of cases as a judge 21:50 - Coping with catastrophic injury and trauma 23:36 - Building confidence through endurance sports 26:54 - Future athletic goals for Justice Bernstein 28:16 - Coping with situational depression and moving forward 32:59 - Future advice: Taking it one day at a time 34:02 - Where to follow Justice Bernstein's journey 34:28 - Story of Jacob and the angel 36:11 - Closing blessings Connect with Justice Bernstein: Facebook: Richard Bernstein Instagram: justicerichardbernstein Check out my FREE reading list: ⁠⁠https://insidetheinspired.com/reading⁠⁠ For all of the courses, podcasts, blogs, contact, and merch, check out our website: ⁠⁠https://insidetheinspired.com⁠⁠⁠ Listen on Apple Podcasts: ⁠⁠https://podcasts.apple.com/us/podcast⁠⁠ Listen on Spotify: ⁠⁠https://open.spotify.com/show/1FV1VqP⁠⁠ Follow Jonathan on Instagram: @jonathanzcohen Rate, review, and subscribe to our podcast on your favorite platform! Your feedback helps us bring you the best possible content and grow our community.

-Gargi Chaudhuri, BlackRock Head of iShares Investment Strategy Americas-Richard Bernstein, Richard Bernstein Advisors CEO & CIO-Stephanie Roth, Wolfe Research Chief Economist Gargi Chaudhuri, Head of iShares Investment Strategy Americas at BlackRock, advises investing in medium-term treasury bonds amid a higher inflationary environment. Richard Bernstein, Richard Bernstein Advisors CEO & CIO, cautions against fixating solely on the Magnificent 7 stocks. Stephanie Roth, Wolfe Research Chief Economist, reacts to weekly jobless claims and says inflation should come down towards 2% without stifling growth.See omnystudio.com/listener for privacy information.

On episode 130 of The Compound and Friends, Michael Batnick and Downtown Josh Brown are joined by Richard Bernstein to discuss: the magnificent 7 compared to past bubbles, bitcoin as a sentiment indicator, the Fed's predicament, the case for international stocks, and much more! Thanks to Carta for sponsoring this episode. See how Carta can simplify your equity plan management today by going to carta.com/compound. Check out the latest in financial blogger fashion at The Compound shop: https://www.idontshop.com Investing involves the risk of loss. This podcast is for informational purposes only and should not be or regarded as personalized investment advice or relied upon for investment decisions. Michael Batnick and Josh Brown are employees of Ritholtz Wealth Management and may maintain positions in the securities discussed in this video. All opinions expressed by them are solely their own opinion and do not reflect the opinion of Ritholtz Wealth Management. The Compound Media, Incorporated, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. For additional advertisement disclaimers see here https://ritholtzwealth.com/advertising-disclaimers. Investments in securities involve the risk of loss. Any mention of a particular security and related performance data is not a recommendation to buy or sell that security. The information provided on this website (including any information that may be accessed through this website) is not directed at any investor or category of investors and is provided solely as general information. Obviously nothing on this channel should be considered as personalized financial advice or a solicitation to buy or sell any securities. See our disclosures here: https://ritholtzwealth.com/podcast-youtube-disclosures/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode I revisit Louis Menand's collection of Pragmatist writings, Pragmatism: A Reader, with an eye toward the more recent writers. I discuss Richard Rorty's Postmodernist Bourgeois Liberalism and Richard Bernstein's Pragmatism, Pluralism, and the Healing of Wounds.

Thank you for joining us for another episode of the Low Carb MD Podcast. R.D. Dikeman, PhD, is a theoretical physicist and loving husband of Roxanne Dikeman, PhD, a clinical psychologist. Their world was turned upside down when their young son David was diagnosed with type 1 diabetes. After following conventional dietary advice for this condition led to uncontrollable blood sugar, dangerous “hypos,” and many sleepless nights, R.D. discovered the work of Dr. Richard Bernstein, MD, a medical doctor who has used a low-carbohydrate diet to control his own type 1 diabetes for more than fifty years and pioneered some of the most groundbreaking research on low-carbohydrate diets for diabetes in the modern era. Through working closely with Dr. Bernstein and as a founder of the Type One Grit online community, R.D. has helped provide thousands of other individuals and families living with type 1 diabetes with information to reduce the threat of complications and attain the truly normal blood sugars that all type 1 diabetics deserve. In this episode, Drs. Tro, Brian, and RD talk about what drew RD into the world of Type 1 Diabetes treatment, RD's son's Type 1 diagnosis, how the Type One Grit group came to be, why low carb is the optimal diet for diabetics, how to still eat what you want on a low-carb diet, big problems with the ADA, why Type One athletes do better on a low carb diet, the upcoming Low Carb Boca conference, and why having courage and integrity is needed in order to bring life saving information to Type One diabetics. For more information, please see the links below. Thank you for listening! Links: RD Dikeman, PhD: Typeonegrit Facebook Page Twitter Diabetes University Dr. Brian Lenzkes: Website Twitter Dr. Tro Kalayjian: Website Twitter Instagram Doctor Tro App Join a growing community of individuals who are improving their metabolic health; together. Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more. Apple Google Learn more

With 2024 underway, Richard Bernstein rejoins the podcast to share RBA's economic and market outlook, as well as discusses investment views, monetary policy, and market risk factors with Jason Draho. Featured are Jason Draho, Head of Asset Allocation Americas with the UBS Chief Investment Office, and Richard Bernstein, Founder, Chief Executive Officer and Chief Investment Officer of Richard Bernstein Advisors. Host: Daniel Cassidy

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comThis week on the podcast Mikki speaks to RD Dikeman, about low carbohydrate diets for people with type 1 diabetes. They discuss how RD's life was turned upside down when his son Dave was diagnosed with type 1 diabetes in 2013 and how the discovery of Dr Richard Bernstein's book ‘The Diabetes Solution'  transformed the management of Dave's condition, helped improve RD's own health, and was the catalyst for RD to take on the job of making the information of how to adopt a low carbohydrate approach accessible. He's responsible for setting up the Type 1 Grit group (of which there is now published data on the success of these individuals), and for hundreds of hours of interviews with Dr Bernstein (who has himself managed his own type 1 diabetes for over 40 years with low carbohydrate) in an effort to educate and inform. They also discuss the common myths that circulate about low carbohydrate diets and type 1 diabetes and so much more. Paper: https://pubmed.ncbi.nlm.nih.gov/29735574/Dr Bernstein's book https://www.amazon.com.au/Dr-Bernsteins-Diabetes-Solution-Achieving/dp/0316182699 RD Dikeman on X: https://twitter.com/DikemanDave RD Dikeman is a theoretical physicist and producer of Dr. Richard Bernstein's Diabetes University, a series of free videos on YouTube on how best to manage diabetes. He's also co-founder of TYPEONEGRIT, an awesome Facebook group for folks aged between one to 81, following Dr. Bernstein's low carb approach to achieving healthy, normal, non-diabetic blood sugars Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwillidenCurranz supplement: MIKKI saves you 25% at www.curranz.co.nz or www.curranz.co.uk ooff your first order

Episode 2429 - On this Friday's show Vinnie Tortorich welcomes back Dr. Ryan Attar and they discuss making noise about diabetes, GLP-1s, and more. https://vinnietortorich.com/2023/12/making-noise-dr-ryan-attar-episode-2429 PLEASE SUPPORT OUR SPONSORS   YOU CAN WATCH THIS EPISODE ON YOUTUBE - Making Noise Dr. Ryan Attar became a Type 1 diabetic in his adult years. (2:30) Type 1 diabetes used to be called "childhood diabetes." You can become T1D at any age. Vinnie shares his friend Bethany McKenzie's story. (6:25) Her child is T1D, but she and her husband were able to find ways to help their child. When she shared what she was doing with her doctor, his response was disturbing. Ryan explains more about T1D and the program he uses based on the research of Dr. Richard Bernstein. (10:30) Vinnie wants to know why there is so much pushback from the ADA and the diabetic and medical communities. (16:45) Ryan is making noise on X by challenging Dr. Bob Gabbay and the ADA. He discusses the “standard of care” document the ADA releases each year and his problems with it. The popularity of GLP-1 medications is (and isn't) astounding. Yes, a person can lose weight on those medications, but they damage your gut, muscles, and bones. The ADA accepts donations from Big Parma. It seems most people just expect to be on a slew of medications by the time they reach age 50. They discuss the problems they have with prominent vegan doctors. (40:00) You can find Dr. Rayan Attar at [the_ad id="20253"] PURCHASE BEYOND IMPOSSIBLE (2022) The documentary launched on January 11! Order it TODAY! This is Vinnie's third documentary in just over three years. Get it now on Apple TV (iTunes) and/or Amazon Video! Link to the film on Apple TV (iTunes):  Then, Share this link with friends, too! It's also now available on Amazon (the USA only for now)!  Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter!  

Diane Kopelakis, MS, RD, introduces herself as "The Evolved Dietitian®"!Diane explains that she adopted this title due to her personal journey of evolving and reforming herself from the nutritional misconceptions that have been prevalent for the past 50+ years. She emphasizes the importance of continuous evolution for health professionals to prevent such harm in the future. Diane is a registered and licensed dietitian with 30 years of experience in clinical dietetics, community nutrition, fitness, and corporate wellness. She utilizes her diverse background, including the implementation of various psychosocial models of habit change, to effectively coach individuals and groups in achieving and maintaining their goals. Diane's unique talents lie in her research and training in metabolic health and resilience, which enable her to offer a comprehensive and successful wellness approach. She offers her assistance in improving health and wellness issues through her empowering C.L.E.A.R. Approach to Wellness®. Diane provides counseling services to individuals, couples, families, and worksites. EPISODE CORRECTION FROM DIANE- "When I said Richard Bernstein regarding uric acid, I meant Dr. Richard Johnson." Find Diane at-IG- @theevolveddietitianTW- @EvolvedRD https://www.theevolveddietitian.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!

In the legal profession, admitting one's own cognitive or mental weakness is a huge taboo. That made it all the more remarkable when Richard Bernstein, a sitting Michigan Supreme Court Justice, announced earlier this year that he was temporarily stepping down to seek treatment for depression. Bernstein was already an extraordinary jurist. He was born fully blind, but overcame his disability to not only graduate from law school but go on to be elected a judge. But stepping away from the bench and publicly admitting he needed treatment might have been the most difficult obstacle he has had to overcome in his career. Bloomberg Law reporter Alex Ebert spoke to Bernstein about his decision and about what this could mean for his future. Ebert joins our weekly news podcast, On The Merits, to talk about Bernstein and about why the legal profession lags behind the rest of society in accepting mental health struggles. Do you have feedback on this episode of On The Merits? Give us a call and leave a voicemail at 703-341-3690.

Dan rejoins the podcast to provide his near-to-medium term outlook for the US economy, monetary policy, and equity markets. We also discuss where Dan is finding opportunity within equities, as well as the risks to be mindful of as we approach the new year and into early 2024. Featured is Dan Suzuki, Deputy Chief Investment Officer at Richard Bernstein Advisors. Host: Daniel Cassidy

Barron's Nicholas Jasinski speaks with Richard Bernstein, CEO and CIO of Richard Bernstein Advisors, a global-macro investment firm, on the outlook for the economy, financial markets, and Federal Reserve policy.

A lot has evolved in the markets since we last spoke with Richard Bernstein back in January. We discuss how we got to where we are today in the markets, how economic conditions might progress in the months ahead, along with views on equity valuations, monetary policy and much more. Plus, thoughts on positioning and investment themes. Featured are Jason Draho, Head of Asset Allocation Americas with the UBS Chief Investment Office, and Richard Bernstein, Founder, Chief Executive Officer and Chief Investment Officer of Richard Bernstein Advisors. Host: Daniel Cassidy

Diagnosed with Type 1 Diabetes when he was just 11, Dr. Richard Bernstein has lived with the condition for a remarkable 78 years. At the age of 89, he continues to serve patients.   In 1969, he invented self-monitoring of blood glucose, revolutionizing the way patients could manage their condition. He further changed the game in 1970, inventing the basal/bolus insulin dosing technique, providing a more efficient approach to diabetes management.  Since 1971, he has followed a low carbohydrate diet, proving that careful nutrition management can play a key role in controlling diabetes. Beyond his own personal practice, Dr. Bernstein has been an active advocate and educator, having penned the authoritative guide, "Dr. Bernstein's Diabetes Solution". He has also created "Dr. Bernstein's Diabetes University", a video series accessible via the internet that provides comprehensive insights into the world of diabetes management.  Timestamps: 00:00:00 Trailer and introduction. 00:01:36 Columbia journey, medical struggles, blood sugar battle. 00:10:44 Gary Taubes exposed bribery for nutritional recommendations. 00:17:58 A trial on blood sugar treatment retracted.  00:22:02 Low carb diet can help manage diabetes. 00:29:02 Morning exercise raises blood sugar levels.  00:37:46 Erectile dysfunction linked to low blood sugar. 00:45:04 Hypoglycemia not direct cause of dementia.  00:49:58 Protein, low-carb vegetables, simple meals. Active lifestyle. 00:57:28 High protein diets may harm diabetic kidneys. 01:02:30 Limited research opportunities hindered publication and recognition. 01:07:28 "Eating less carbs for lower blood sugar." 01:13:06 Controversial trend: carnivore diet and diabetes. 01:19:26 Abdominal fat types and exercise regimen. See open positions at Revero: https://jobs.lever.co/Revero/ Join Carnivore Diet for a free 30 day trial: https://carnivore.diet/join/ Carnivore Shirts: https://merch.carnivore.diet Subscribe to our Newsletter: https://carnivore.diet/subscribe/ . ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪

Welcome to Protecting Your Nest with Dr. Tony Hampton. RD Dikeman is a theoretical physicist, a producer on Diabetes University on YouTube, and co-founder of the Facebook community, Type One Grit. In this discussion, Dr. Tony and RD talk about: (03:22) What it means to be a theoretical physicist and how this field relates to nutrition and diet (15:10) Dr. Richard Bernstein's book, Diabetes Solution (19:12) How quickly a person with Type 1 can normalize their blood sugars (30:43) Why carbs are not as important as is often believed (37:05) Protein and Type 1 Diabetes (45:42) The usage of insulin pumps on the low-carb diet (53:17) Eating vegetables on a low-carb diet and using pumps (55:06) Advice for those trying to live a low-carb lifestyle but who also want to have cheat days (59:13) Alcohol (01:03:22) The complications of Type 1 Diabetes Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.    Links:   RD Dikeman: Adapt Type-1 Diabetes Course Diabetes University Type One Grit   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures How Waking Up Every Day at 4:30 Can Change Your Life

Nayiri's professional background lies in linguistics, education, and translation. She is the founder and director of a translation company, which she runs alongside her coaching and research work.  Additionally, she works as a health coach at Low Carb and Fasting. Her passion is researching type 1 diabetes. She administers a Facebook group for type 1s who follow the keto and fasting lifestyle for improved health. She has been living with type 1 diabetes for 45 years. Since 2015, she has been following a low-carb diet, and adopted a ketovore/carnivore lifestyle in 2021, after being a vegetarian/vegan for 30 years. She is passionate about sharing her journey to better health. One can check out her YouTube channel at www.youtube.com/@LowCarbandFasting for more information. Timestamps: 00:00:00 Meat solved fatigue, bacon helped pancreas, winning game. 00:03:50 Diabetes led to dietary and career changes. 00:07:17 Insulin dosage for protein with CGM. 00:13:33 30-year vegetarian discovers need for meat. 00:20:21 Rejected medical advice led me to change. 00:25:07 Diabetes patient switches to DexCom G6. 00:27:28 Managing blood sugar levels with microdoses and CGM. 00:32:04 Protein upped, helped build muscle, health improved. 00:36:05 "Intermittent fasting for blood sugar control, extended fasts" 00:44:06 Manage stress, prioritize sleep, and anticipate changes. 00:47:10 Pancreas functions impact carbohydrates and insulin dosage. 00:51:17 Carbon testing: double & more, Richard Bernstein. See open positions at Revero: https://jobs.lever.co/Revero/ Join Carnivore Diet for a free 30 day trial: https://carnivore.diet/join/ Carnivore Shirts: https://merch.carnivore.diet Subscribe to our Newsletter: https://carnivore.diet/subscribe/ . ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪

Bloomberg Radio host Barry Ritholtz speaks with Richard Bernstein, the chief executive officer and chief investment officer of Richard Bernstein Advisors LLC, which manages $14.6 billion in assets. Bernstein, who was previously chief investment strategist at Merrill Lynch, has been named to the Institutional Investor's “All-America Research Team” 18 times and has been inducted into the Institutional Investor Hall of Fame. He is also the author of “Style Investing: Unique Insight into Equity Management,” which is widely viewed as the seminal book on style-oriented investment strategies, as well as “Navigate the Noise: Investing in the New Age of Media and Hype.”See omnystudio.com/listener for privacy information.

Pam Anderson's new doc filled with old pictures, WATP Karl joins us, Joe Biden's classified documents, kids accessing porn, not-a-Prince Harry's whoppers, SBF's FTX spending, Tennessee police sex romps, and Idaho murderer Brian Kohbooger's Tinder date speaks. Sports: The Georgia Bulldogs destroyed the TCU Horned Frogs in the CFB National Championship. Buffalo Bill Damar Hamlin is now walking. Sunday Night Football starring the Detroit Lions was ratings gold. Bryan Kohberger Updates: His vehicle was spotted driving near the house after the murders. None of the victims appeared to know the killer. Surviving roommate, Dylan Mortensen, is being harassed online. Kohbooger's Tinder date has broken her silence. Brian Walshe is a bad murderer and doesn't know how to use Google. He needs to go into the sweatbox and admit he murdered his wife. Kids have so much access to porn. Local 4 is here to educate you with some fantastic women on the street. We recommend showing your kids Molly Grows Up for their sex ed. Prince Harry wants you to know the circumcision etiquette of the Royal Family. He's been caught in many lies thus far. Karl from WATP joins the show to discuss a new subreddit dedicated to Shuli Egar, continue the conversation of the awful High Low with EmRata (featuring Bella Thorne), rip Kato Kaelin's podcast to shreds and much more. BranDon's appearance is now available on YouTube. Get your tickets to DabbleCon today. Grab your EXCLUSIVE NordVPN Deal by going to nordvpn.com/dams to get up a Huge Discount off your NordVPN Plan + 4 months for free! It's completely risk free with Nord's 30-day money-back guarantee. Michigan Supreme Court Justice, Richard Bernstein, is sorry for giving fellow justice Kyra Harris Bolden crap about hiring felon Peter Martel. Celebrity Updates: Alec Baldwin begs his fans to follow his Spanish wife, Hilarious. Pamela Anderson is putting out a new documentary... about her. Pussycat Doll, Kaya Jones, is opening up about all her abortions. Carla Bruni is in trouble for a fantastic Meghan Markle/Yoko Ono photoshop. Adam Rich's obit remains a top story on TMZ. Scott Baio's team photo is insane. Some people are saying Amy Robach and TJ Holmes' exes are hooking up. It's totally cool to cheat on your significant other if you pay all the bills. Right, Gabrielle Union? Madoff: The Monster of Wall Street doesn't add too much to the Bernie Madoff scandal, but we learn some new details. Sam Bankman-Fried wants his Robinhood shares to pay for his FTX defense. Unfortunately the Department of Justice has seized it. Classified files have been found in one of Joe Biden's house. Donald Trump wants "equal treatment". That 6-year-old that shot his teacher got the gun from his mother. The robber that was shot and killed by a vigilante in Texas had quite the rap sheet. Former Walmart greeter Butch Marion is STILL racking up the GoFundMe money. The University of Michigan really needs to work on their diversity. A bunch of Tennessee police officers are BLOWN OUT for nailing some chick cop who loved every single dong on the force. Visit Our Presenting Sponsor Hall Financial – Michigan's highest rated mortgage company Social media is dumb, but we're on Facebook, Instagram and Twitter (Drew and Mike Show, Marc Fellhauer, Trudi Daniels and BranDon).

Shoppers may need to switch from steak to bologna, but they still need to eat. That's just one reason for investors to watch consumer staples if you're concerned about a recession. Richard Bernstein is the CEO and Chief Investment Officer of Richard Bernstein Advisors. Before that he was the Chief Investment Strategist at Merrill Lynch. Motley Fool Senior Analyst John Rotonti caught up with Bernstein to discuss:  - How growth stories can change through time.  - Sectors showing the power of compounding dividends.  - If a “Fed Put” still exists.  Members of any Motley Fool service can watch the full interview here: https://www.fool.com/premium/live/video/4056/coverage/2022/11/16/interview-richard-bernstein-ceo-cio-richard-bernst/  Host: John Rotonti Guest: Richard Bernstein Producer: Ricky Mulvey  Engineers: Heather Horton, Dan Boyd

On today's show, we sit down with Michigan Supreme Court Justice, the Honorable Justice Richard Bernstein! Justice Bernstein discusses his upcoming re-election for the MI Supreme Court as well as his incredibly inspirational story making history as the first blind justice - elected by voters statewide - to the Michigan Supreme Court. The remainder of the episode we discuss the latest breaking news of the week to keep you up to date. We break down the story of Trump telling his inner-circle that he plans to run for president again to avoid criminal probes, John Fetterman's campaign for PA Senate absolutely wiping the floor with Dr. Oz, Lauren Boebert's bizarre book tour and much more. New episodes of The MeidasTouch Podcast with Ben, Brett & Jordy are released every Tuesday & Friday at 5am ET. Please be sure to rate, review and subscribe! Thank YOU for listening. Shop Meidas Merch at: https://store.meidastouch.com Remember to subscribe to ALL the Meidas Media Podcasts: MeidasTouch: https://pod.link/1510240831 Legal AF: https://pod.link/1580828595 The PoliticsGirl Podcast: https://pod.link/1595408601 The Influence Continuum: https://pod.link/1603773245 Kremlin File: https://pod.link/1575837599 Mea Culpa with Michael Cohen: https://pod.link/1530639447 The Weekend Show: https://pod.link/1612691018 The Tony Michaels Podcast: https://pod.link/1561049560 Learn more about your ad choices. Visit megaphone.fm/adchoices